CA A Cancer Journal for Clinicians· 2020Q1
Colorectal cancer statistics, 2020
- 5,144citations
- Q1SCImago
- 2020year
Short summary
In 2020, 147,950 US individuals will be diagnosed with colorectal cancer (CRC), and 53,200 will die from it, with incidence rising 2% annually in those under 50.
AI-generated from the title and abstract; the full text is not read.
Key points
- Approximately 147,950 new colorectal cancer (CRC) cases and 53,200 deaths are projected for 2020 in the US.
- Incidence rates for CRC are increasing by ~2% annually in individuals younger than 50.
- Mortality rates are declining in older adults (65+) but increasing in those younger than 50.
- Incidence rates vary significantly by race/ethnicity, with Alaska Natives having the highest rates.
AI-generated from the title and abstract; the full text is not read.
Abstract
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC occurrence based on incidence data (available through 2016) from population-based cancer registries and mortality data (through 2017) from the National Center for Health Statistics. In 2020, approximately 147,950 individuals will be diagnosed with CRC and 53,200 will die from the disease, including 17,930 cases and 3,640 deaths in individuals aged younger than 50 years. The incidence rate during 2012 through 2016 ranged from 30 (per 100,000 persons) in Asian/Pacific Islanders to 45.7 in blacks and 89 in Alaska Natives. Rapid declines in incidence among screening-aged individuals during the 2000s continued during 2011 through 2016 in those aged 65 years and older (by 3.3% annually) but reversed in those aged 50 to 64 years, among whom rates increased by 1% annually. Among individuals aged younger than 50 years, the incidence rate increased by approximately 2% annually for tumors in the proximal and distal colon, as well as the rectum, driven by trends in non-Hispanic whites. CRC death rates during 2008 through 2017 declined by 3% annually in individuals aged 65 years and older and by 0.6% annually in individuals aged 50 to 64 years while increasing by 1.3% annually in those aged younger than 50 years. Mortality declines among individuals aged 50 years and older were steepest among blacks, who also had the only decreasing trend among those aged younger than 50 years, and excluded American Indians/Alaska Natives, among whom rates remained stable. Progress against CRC can be accelerated by increasing access to guideline-recommended screening and high-quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle-aged adults.
The authors' abstract, as published at the source. CA A Cancer Journal for Clinicians, 2020 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Oncology
OncologyMedicine